Interstitial Low Dose Rate Brachytherapy for Prostate Cancer - A Focus on Intermediate- and High-risk Disease

Although the role of combination treatment with pelvic EBRT and androgen therapy is not clear, our early results show that many patients with intermediate- and high-risk disease have excellent results with brachytherapy.